Comparison of different methods of administering droperidol in patient-controlled analgesia in the prevention of postoperative nausea and vomiting.

Author: AlexanderR, FennellyM, GanT J, RubinA P

Paper Details 
Original Abstract of the Article :
We performed a double-blind, placebo-controlled study to evaluate the different methods of administering droperidol in patients using patient-controlled analgesia (PCA) with morphine. Eighty patients undergoing major orthopedic procedures received temazepam 0.2 mg/kg orally followed by induction of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00000539-199501000-00014

データ提供:米国国立医学図書館(NLM)

Droperidol's Role in Patient-Controlled Analgesia: A Comparative Study

This double-blind, placebo-controlled study investigated the efficacy of different methods of administering droperidol in patients using patient-controlled analgesia (PCA) with morphine. The authors sought to optimize the use of droperidol in preventing postoperative nausea and vomiting (PONV) while minimizing sedation. The study compared various administration methods, including a single bolus dose of droperidol at the end of surgery, a continuous infusion with each PCA dose, and a combination of both.

Droperidol's Effectiveness in Preventing PONV

The research demonstrated that droperidol significantly reduced the incidence of PONV and the need for rescue antiemetics compared to placebo. However, the study found no significant difference in PONV reduction between administering droperidol as a single dose at the end of surgery or mixed in morphine PCA. The authors concluded that combining an initial bolus dose with continuous infusion in PCA should be avoided due to increased sedation and no additional benefit in reducing PONV.

Optimizing Droperidol Administration for Postoperative Nausea

This research provides valuable insights for optimizing the use of droperidol in preventing PONV. The study's findings suggest that administering droperidol as a single bolus dose at the end of surgery is as effective as continuous infusion with each PCA dose. The authors recommend avoiding the combination of both methods to minimize sedation and optimize patient comfort.

Dr.Camel's Conclusion

This study delves into the intricate world of postoperative nausea and vomiting, seeking to optimize the use of droperidol in preventing this common complication. The authors' meticulous research provides valuable insights into the optimal administration methods for droperidol, guiding clinicians towards more effective and patient-centered care. This research underscores the importance of considering the individual needs of patients and tailoring treatment strategies accordingly.

Date :
  1. Date Completed 1995-01-24
  2. Date Revised 2019-07-03
Further Info :

Pubmed ID

7802306

DOI: Digital Object Identifier

10.1097/00000539-199501000-00014

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.